Opinion|Videos|April 8, 2025
Addressing the Patient/Provider Disconnect in Reported Pain
Author(s)Lisa Bayer, MD, MPH
Panelists discuss how physicians consistently underestimate intrauterine device (IUD) placement pain compared to patients’ reported experiences. They emphasize that addressing this disparity requires physician humility, community education initiatives, and adherence to standardized guidelines such as the CDC’s updated 2024 pain management recommendations.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Studies show that physicians underestimate IUD placement pain compared with their patients’ reported pain.
- In addressing this, humility, work toward community education, and standardized guidelines are key (CDC updated guidance in 2024 on pain management).
Advertisement
Related to this article
The 16-item Perimenopause Symptom Scale showed strong reliability and validity among 1255 women aged 35 to 59 years in the United States.
Patients with 3 or more adverse pregnancy outcomes had lower odds of postpartum contraceptive use in a PRAMS analysis of 222,412 individuals.
Kanchi Chadha, MD, FACOG, MSCP, supports reconsidering MHT boxed warnings but says the FDA cited no study behind the change.
HRSA will award up to $1 million to a single organization to update the Women's Preventive Services Guidelines through the new WISH program.
Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.
Soma Mandal, MD, MSCP, says removing MHT boxed warnings is overdue but calls for transparency on the FDA's product-specific rationale.
Peter Hsin, BS, discusses a meta-analysis linking perioperative ketamine to lower early postpartum depressive symptoms after cesarean delivery.
Susan Reed, MD, MPH, MS, and Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, weigh in on FDA boxed warning removals for menopausal hormone therapy.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
What biomarker-guided preeclampsia care could look like
2
Testosterone for women: Global consensus and physiologic dosing
3
Testosterone physiology in women and the long road to approval
4
Testosterone in women: Androgenic adverse events and lab monitoring
5